NCT00927667 - Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens | Biotech Hunter

Enrollment

156

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Hemophilia A

Interventions

PROCEDURE

No Drug

Patients have received primary FVIII prophylaxis (started \< 2 years of age)

PROCEDURE

No Drug

Patients have received secondary FVIII prophylaxis (started 2 - \< 6 years of age)

PROCEDURE

No Drug

Patients have received secondary FVIII prophylaxis (started 6 - \< 12 years of age)

PROCEDURE

No Drug

Patients have received secondary VIII prophylaxis(started 12 - 18 years of age)

PROCEDURE

No Drug

Patients have received on-demand therapy

Trial Locations (15)

15006

A Coruña

20122

Milan

35121

Padua

39112

Magdeburg

43100

Parma

46026

Valencia

48143

Münster

53105

Bonn

69123

Heidelberg

115 27

Athens

00161

Roma

205 02

Malmo

171 76

Stockholm

CT1 3NG

Canterbury

NW3 2QG

London